MARKET

AZN

Astrazeneca Plc
AZN
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
41.22
5.32
6.27
287,755,456,775.58
AstraZeneca's Baxfendy Wins FDA Approval As First-In-Class Aldosterone Synthase Inhibitor For Uncontrolled Hypertension
Benzinga · 1h ago
Reported Friday, AstraZeneca And Daiichi Sankyo's ENHERTU Wins FDA Approval In Neoadjuvant And Adjuvant HER2-Positive Early Breast Cancer
Benzinga · 3h ago
PRESS DIGEST -Wall Street Journal - May 18
Reuters · 3h ago
AstraZeneca says FDA approves Enhertu for HER2-positive early breast cancer indications
PUBT · 4h ago
AstraZeneca Gets U.S. Approval for Hypertension Drug
Dow Jones · 4h ago
AstraZeneca says FDA approves Baxfendy for adults with hypertension in US
PUBT · 4h ago
ASTRAZENECA: BAXFENDY APPROVED IN US AS FIRST ALDOSTERONE SYNTHASE INHIBITOR TREATMENT FOR ADULTS WITH HYPERTENSION
Reuters · 4h ago
AstraZeneca's blood pressure drug wins U.S. approval
Reuters · 4h ago
More

Webull offers Astrazeneca Plc stock information, including NASDAQ: AZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AZN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AZN stock methods without spending real money on the virtual paper trading platform.